194 related articles for article (PubMed ID: 38355641)
1. "Make yourself un-NIMBY-able": stakeholder perspectives on strategies to mobilize public and political support for overdose prevention centers in the United States of America.
Rosen JG; Thompson E; Tardif J; Collins AB; Marshall BDL; Park JN
Harm Reduct J; 2024 Feb; 21(1):40. PubMed ID: 38355641
[TBL] [Abstract][Full Text] [Related]
2. "Politics Versus Policy": Qualitative Insights on Stigma and Overdose Prevention Center Policymaking in the United States.
Koehm K; Rosen JG; Yedinak Gray JL; Tardif J; Thompson E; Park JN
Subst Use Addctn J; 2024 May; ():29767342241253663. PubMed ID: 38804608
[TBL] [Abstract][Full Text] [Related]
3. Association between willingness to use an overdose prevention center and probation or parole status among people who use drugs in Rhode Island.
Tan M; Park C; Goldman J; Biello KB; Buxton J; Hadland SE; Park JN; Sherman SG; Macmadu A; Marshall BDL
Harm Reduct J; 2024 Feb; 21(1):54. PubMed ID: 38424553
[TBL] [Abstract][Full Text] [Related]
4. Perspectives of U.S. harm reduction advocates on persuasive message strategies.
White SA; Lee R; Kennedy-Hendricks A; Sherman SG; McGinty EE
Harm Reduct J; 2023 Aug; 20(1):112. PubMed ID: 37596595
[TBL] [Abstract][Full Text] [Related]
5. In Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction).
Dunham K; Hill K; Kazal H; Butner JL; Hull I; Sue K; Li L; Doneski K; Dinges B; Rife-Pennington T; Kung S; Thakarar K
Subst Use Addctn J; 2024 Jul; 45(3):328-336. PubMed ID: 38747578
[TBL] [Abstract][Full Text] [Related]
6. The Nation's First Publicly Recognized Overdose Prevention Centers: Lessons Learned in New York City.
Giglio RE; Mantha S; Harocopos A; Saha N; Reilly J; Cipriano C; Kennelly M; Landau L; McRae M; Chokshi DA
J Urban Health; 2023 Apr; 100(2):245-254. PubMed ID: 37016269
[TBL] [Abstract][Full Text] [Related]
7. Using drugs in un/safe spaces: Impact of perceived illegality on an underground supervised injecting facility in the United States.
Davidson PJ; Lopez AM; Kral AH
Int J Drug Policy; 2018 Mar; 53():37-44. PubMed ID: 29278831
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on supervised injection facilities among service industry employees in New York City: A qualitative exploration.
Wolfson-Stofko B; Elliott L; Bennett AS; Curtis R; Gwadz M
Int J Drug Policy; 2018 Dec; 62():67-73. PubMed ID: 30359875
[TBL] [Abstract][Full Text] [Related]
9. Overdose Prevention Centers, Crime, and Disorder in New York City.
Chalfin A; Del Pozo B; Mitre-Becerril D
JAMA Netw Open; 2023 Nov; 6(11):e2342228. PubMed ID: 37955901
[TBL] [Abstract][Full Text] [Related]
10. Establishing Sanctioned Safe Consumption Sites in the United States: Five Jurisdictions Moving the Policy Agenda Forward.
Kennedy-Hendricks A; Bluestein J; Kral AH; Barry CL; Sherman SG
Psychiatr Serv; 2019 Apr; 70(4):294-301. PubMed ID: 30755131
[TBL] [Abstract][Full Text] [Related]
11. Hoots and harm reduction: a qualitative study identifying gaps in overdose prevention among women who smoke drugs.
Bardwell G; Austin T; Maher L; Boyd J
Harm Reduct J; 2021 Mar; 18(1):29. PubMed ID: 33678163
[TBL] [Abstract][Full Text] [Related]
12. Policing space in the overdose crisis: A rapid ethnographic study of the impact of law enforcement practices on the effectiveness of overdose prevention sites.
Collins AB; Boyd J; Mayer S; Fowler A; Kennedy MC; Bluthenthal RN; Kerr T; McNeil R
Int J Drug Policy; 2019 Nov; 73():199-207. PubMed ID: 31542327
[TBL] [Abstract][Full Text] [Related]
13. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
Foreman-Mackey A; Pauly B; Ivsins A; Urbanoski K; Mansoor M; Bardwell G
Subst Abuse Treat Prev Policy; 2022 Oct; 17(1):66. PubMed ID: 36209227
[TBL] [Abstract][Full Text] [Related]
14. Stakeholder perspectives on implementing fentanyl drug checking: Results from a multi-site study.
Glick JL; Christensen T; Park JN; McKenzie M; Green TC; Sherman SG
Drug Alcohol Depend; 2019 Jan; 194():527-532. PubMed ID: 30551090
[TBL] [Abstract][Full Text] [Related]
15. Willingness to Use Safe Consumption Spaces among Opioid Users at High Risk of Fentanyl Overdose in Baltimore, Providence, and Boston.
Park JN; Sherman SG; Rouhani S; Morales KB; McKenzie M; Allen ST; Marshall BDL; Green TC
J Urban Health; 2019 Jun; 96(3):353-366. PubMed ID: 31168735
[TBL] [Abstract][Full Text] [Related]
16. Law enforcement attitudes toward overdose prevention and response.
Green TC; Zaller N; Palacios WR; Bowman SE; Ray M; Heimer R; Case P
Drug Alcohol Depend; 2013 Dec; 133(2):677-84. PubMed ID: 24051061
[TBL] [Abstract][Full Text] [Related]
17. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
[TBL] [Abstract][Full Text] [Related]
18. Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: A qualitative study exploring challenges and mitigating strategies.
Childs E; Biello KB; Valente PK; Salhaney P; Biancarelli DL; Olson J; Earlywine JJ; Marshall BDL; Bazzi AR
Int J Drug Policy; 2021 Apr; 90():103080. PubMed ID: 33340947
[TBL] [Abstract][Full Text] [Related]
19. "I Don't Go Overboard": Perceptions of Overdose Risk and Risk Reduction Strategies among People Who Use Drugs in Rhode Island.
Collins AB; Kaplowitz E; Bastani P; McKee H; Whitaker D; Hallowell BD; McKenzie M
Subst Use Misuse; 2024; 59(5):673-679. PubMed ID: 38124349
[No Abstract] [Full Text] [Related]
20. "It gets you high as a kite but not unsick": Characterizations of and responses to a changing local drug supply by people who use drugs in Rhode Island.
Collins AB; Macon EC; Levin S; Wunsch C; Wightman RS
Int J Drug Policy; 2024 May; 127():104391. PubMed ID: 38490014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
